Clinical Trials Sponsored by Cardiac Science Corporation.

Total 631 results

Seattle Institute for Cardiac Research
Cardiac Science Corporation.

Completed

The Simple ECG Monitoring Trial (Comparison of a Novel Recording System With a Standard Holter Monitor)

Atrial Fibrillation | Syncope | Supraventricular Tachycardia | Pre-syncope

United States, New Zealand
Cardiox Corporation

Terminated

Cardiox Shunt Detection Technology Study

Patent Foramen Ovale

United States
Cardiox Corporation

Withdrawn

Cardiox Liver Function Test Pivotal Trial (LFT-0002)

Liver Failure | Hepatic Failure

United States
Cardiox Corporation

Terminated

Liver Function Assessment - Feasibility and Dosing Study

Hepatic Failure
Cardiox Corporation

Terminated

Right to Left Cardiac Shunt Detection (PFO Detection)

Atrial Septal Defect | Patent Foramen Ovale | Right to Left Shunt

United States
Cardiox Corporation
TMJ Health

Unknown

TMJ NextGen Pilot Study to Treat Subjects With Bruxism

Bruxism
TMJ Health
Cardiox Corporation

Withdrawn

TMJ-1001 Bruxism Run-In/Pivotal Trial

Bruxism
Cordis Corporation
Cardinal Health

Completed

Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA)

Endovascular

China
TMJ Health
Cardiox Corporation

Completed

TMJ NextGeneration(TM) Feasibility Study (Bruxoff)

Bruxism

United States
Posit Science Corporation

Active, not recruiting

Remote Digital Health Intervention to Improve Balance and Reduce Fall Risk (rSTAND)

Fall

United States
Posit Science Corporation

Withdrawn

Piloting a Novel, Mobile Cognitive Tracking and Training Tool for Patients With Parkinson's Disease (PD)

Parkinson's Disease
Posit Science Corporation

Completed

Computerized Attention Training for Individuals With Acquired Brain Injury

Stroke | Acquired Brain Injury | Hemispatial Neglect

United States
Posit Science Corporation

Completed

STATE Trial: SusTained Attention Training to Enhance Sleep - Remote (STATE)

Insomnia Chronic

United States
Posit Science Corporation

Completed

Piloting a Novel, Mobile Cognitive Training Tool for Patients With Major Depressive Disorder (MDD) (MDD)

Major Depressive Disorder

United States
M's Science Corporation

Completed

SA4503 8-Week Study in Major Depressive Disorder (MDD)

Depressive Disorder, Major

Finland
Posit Science Corporation

Completed

Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment

Breast Cancer | Memory Disorders | Cognitive Symptoms

United States
Posit Science Corporation

Completed

Cognitive Remediation for HIV-associated Neurocognitive Dysfunction (HAND)

HIV-associated Neurocognitive Dysfunction

United States
Posit Science Corporation

Completed

Computer-Based Training for Cognitive Enhancement: Classroom Study

Aging

United States
Posit Science Corporation

Completed

Computer-Based Training for Cognitive Enhancement: In Home Study

Aging

United States
M's Science Corporation

Completed

Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke

Ischemic Stroke

United Kingdom
Gilead Sciences
University Medicine Göttingen, Cardiac Center

Completed

Ranolazine in Diastolic Heart Failure (RALI-DHF)

Diastolic Heart Failure

Germany
Exact Sciences Corporation

Completed

Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"

Colorectal Cancer

United States
Exact Sciences Corporation

Completed

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors

Kidney Cancer | Stomach Cancer | Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Liver Cancer | Renal Pelvis Cancer | Uterine Cancer

United States
Exact Sciences Corporation

Completed

Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.

Colo-rectal Cancer

United States
Exact Sciences Corporation

Completed

Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program (2016-11)

Healthy

United States
Exact Sciences Corporation

Terminated

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies

Hematologic Malignancy

United States
Exact Sciences Corporation

Terminated

Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers

Digestive System Diseases | Colonic Diseases | Colorectal Neoplasms | Colorectal Cancer

United States, Canada
Protein Sciences Corporation

Completed

Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age

Influenza

United States
Exact Sciences Corporation

Completed

Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)

Digestive System Diseases | Colonic Diseases | Colorectal Neoplasms | Colorectal Cancer | Inflammatory Bowel Disease

United States, Canada
Protein Sciences Corporation

Completed

Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age

Influenza

United States
iScience Interventional Corporation

Completed

Surgical Treatment of Refractory Open Angle Glaucoma

Open Angle Glaucoma

United States
Protein Sciences Corporation

Completed

Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics

Influenza

United States
Exact Sciences Corporation

Recruiting

Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

Colorectal Cancer

United States, Canada
Exact Sciences Corporation

Completed

Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"

Colorectal Cancer

United States
Exact Sciences Corporation

Completed

An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now

Colorectal Cancer

United States
Exact Sciences Corporation

Completed

Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer

Lung Cancer (Diagnosis)

United States
Exact Sciences Corporation

Terminated

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma

Melanoma

United States
Exact Sciences Corporation

Completed

Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold

Colorectal Cancer

United States
Exact Sciences Corporation

Completed

Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease (OCEANIA)

Colorectal Neoplasms | Colorectal Cancer | Inflammatory Bowel Disease (IBD) | Primary Sclerosing Cholangitis (PSC)

United States, Canada
Exact Sciences Corporation

Completed

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer (DeeP-C)

Digestive System Diseases | Colonic Diseases | Colorectal Neoplasms | Colorectal Cancer

United States, Canada
Protein Sciences Corporation

Completed

Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults (PSC25)

Influenza

United States
Exact Sciences Corporation

Completed

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Digestive System Diseases | Colonic Diseases | Colorectal Neoplasms | Colorectal Cancer

United States
Protein Sciences Corporation

Completed

Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults

Influenza

United States
Protein Sciences Corporation

Completed

Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults

Influenza

United States
Exact Sciences Corporation

Recruiting

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Hepatitis B | Hepatocellular Carcinoma | Cirrhosis | Liver Cancer | Hepatocellular Cancer

United States
Exact Sciences Corporation

Completed

Home Usability Study of the SARS-CoV-2 (COVID-19) Test

COVID-19

United States
Exact Sciences Corporation

Completed

Stool Collection Sub-Study of Exact Sciences Protocol 2018-01

Cancer | Colorectal Cancer | Colo-rectal Cancer

United States
Exact Sciences Corporation

Completed

Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

Hepatocellular Carcinoma | Hepatocellular Carcinoma Surveillance

United States, Taiwan, Thailand, Germany, France, Spain, Italy
Exact Sciences Corporation

Terminated

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

Colorectal Cancer

United States
Exact Sciences Corporation

Completed

A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval

Colorectal Cancer | Colorectal Cancer Screening

United States

Clinical Trials Sponsored by Cardiac Science Corporation.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations